Infertility Drugs

Infertility Drugs

Global Infertility Drugs Market to Reach US$7.0 Billion by 2030

The global market for Infertility Drugs estimated at US$4.9 Billion in the year 2023, is expected to reach US$7.0 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Hormone-Based Therapy, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth in the Other Products segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 8.1% CAGR

The Infertility Drugs market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 8.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Infertility Drugs Market - Key Trends & Drivers Summarized>What Are Infertility Drugs and How Do They Support Reproductive Health?

Infertility drugs are medications used to treat reproductive problems in both men and women to increase their chances of conceiving. These drugs generally work by regulating or stimulating ovulation, enhancing sperm production, or correcting hormonal imbalances. In women, common treatments include drugs like Clomiphene citrate, Gonadotropins, and Metformin, which are used to trigger the release of eggs from the ovaries. For men, medications may improve sperm count and quality. The development and use of these drugs are critical as infertility rates have been rising globally, driven by factors such as delayed childbearing, lifestyle changes, and increased prevalence of conditions like polycystic ovary syndrome (PCOS) and endometriosis.

How Are Advances in Medical Research Shaping the Infertility Drugs Market?

The infertility drugs market is continuously shaped by advances in medical research and biotechnology, including the development of more targeted hormone treatments and the introduction of new drug classes. Innovations such as the use of artificial intelligence (AI) to personalize drug protocols based on individual patient responses are enhancing the efficacy and success rates of these treatments. Furthermore, ongoing research into the genetic factors underlying infertility is opening up possibilities for genomic therapies that could correct genetic defects causing reproductive issues. Such advancements not only promise to increase the effectiveness of existing drugs but also help in developing novel therapies with fewer side effects.

What Trends Are Influencing the Demand for Infertility Drugs?

Several trends are currently influencing the demand for infertility drugs. Social trends, including the increasing age of first-time parents, contribute significantly to rising infertility rates, thereby driving the need for effective pharmacological interventions. The growing public awareness and acceptance of fertility treatments, coupled with improvements in healthcare infrastructure, are making these drugs more accessible to a broader population. Moreover, health insurance providers are gradually recognizing the need for comprehensive reproductive health services, including coverage for infertility treatments, which is making these drugs more affordable and further stimulating market growth.

Growth in the Infertility Drugs Market Is Driven by Several Factors

The growth in the infertility drugs market is driven by several factors related to advancements in medical science, changes in socio-economic conditions, and evolving consumer behaviors. Technological progress in drug development and the application of precision medicine are significantly enhancing the effectiveness and reducing the risks associated with infertility treatments. Economic factors, such as increased healthcare spending and the inclusion of fertility treatments in insurance coverage, are making these drugs more accessible and affordable. Additionally, global changes in attitudes towards fertility and an increase in the number of fertility clinics are expanding the consumer base for these drugs. Together, these dynamics are propelling robust growth in the infertility drugs market, reflecting a combination of improved treatment options and broader societal acceptance of fertility issues.

Select Competitors (Total 44 Featured) -
  • Abbott Laboratories
  • AbbVie Inc.
  • Allergan Plc
  • Bayer AG
  • Eli Lilly
  • F. Hoffmann-La Roche Ltd
  • Ferring Pharmaceuticals AS
  • GlaxoSmithKline Plc
  • LIVZON Pharmaceutical Group Inc.
  • Merck & Co. Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Zydus Pharmaceuticals
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Infertility Drugs – Global Key Competitors Percentage Market Share in 2024 (E)
Global Economic Update
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Global Incidence of Infertility Spurs Demand for Advanced Fertility Treatments
Growing Awareness of Reproductive Health Throws Spotlight on Infertility Drug Market Expansion
Advancements in Assisted Reproductive Technologies (ART) Propel Growth in Infertility Drug Use
Increasing Age of First-Time Parenthood Expands Addressable Market for Infertility Drugs
Stringent Regulatory Approvals and Guidelines Drive Adoption of Clinically-Validated Infertility Medications
Demand for Personalized Medicine Strengthens Business Case for Tailored Infertility Treatments
Rising Incidence of Polycystic Ovary Syndrome (PCOS) and Other Reproductive Disorders Drives Drug Demand
Innovation in Hormonal Therapies Generates New Opportunities in Infertility Drug Development
Impact of Lifestyle Factors, Such as Stress and Obesity, on Fertility Propels Demand for Therapeutic Solutions
Increasing Investment in Fertility Clinics and Specialized Healthcare Facilities Expands Market for Infertility Drugs
Growing Use of Combination Therapies in Fertility Treatments Sustains Market Growth
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Infertility Drugs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Infertility Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Infertility Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Infertility Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Hormone-Based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Hormone-Based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Hormone-Based Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 11: USA Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 12: USA Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: USA 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
CANADA
TABLE 14: Canada Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 15: Canada Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: Canada 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
JAPAN
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 17: Japan Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 18: Japan Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: Japan 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
CHINA
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 20: China Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 21: China Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: China 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
EUROPE
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 23: Europe Recent Past, Current & Future Analysis for Infertility Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: Europe Historic Review for Infertility Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: Europe 16-Year Perspective for Infertility Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 26: Europe Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: Europe Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: Europe 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
FRANCE
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 29: France Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: France Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: France 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
GERMANY
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 32: Germany Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Germany Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Germany 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
ITALY
TABLE 35: Italy Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Italy Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Italy 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
UNITED KINGDOM
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 38: UK Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: UK Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: UK 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
SPAIN
TABLE 41: Spain Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Spain Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Spain 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
RUSSIA
TABLE 44: Russia Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Russia Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Russia 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Rest of Europe Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Rest of Europe 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Infertility Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 51: Asia-Pacific Historic Review for Infertility Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Asia-Pacific 16-Year Perspective for Infertility Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Asia-Pacific Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Asia-Pacific 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
AUSTRALIA
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 56: Australia Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Australia Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Australia 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
INDIA
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 59: India Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: India Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: India 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 62: South Korea Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: South Korea Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: South Korea 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Rest of Asia-Pacific Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
LATIN AMERICA
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 68: Latin America Recent Past, Current & Future Analysis for Infertility Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 69: Latin America Historic Review for Infertility Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Latin America 16-Year Perspective for Infertility Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 71: Latin America Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Latin America Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Latin America 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 74: Argentina Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Argentina Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Argentina 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
BRAZIL
TABLE 77: Brazil Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Brazil Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Brazil 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
MEXICO
TABLE 80: Mexico Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Mexico Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Mexico 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Rest of Latin America Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Rest of Latin America 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
MIDDLE EAST
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 86: Middle East Recent Past, Current & Future Analysis for Infertility Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 87: Middle East Historic Review for Infertility Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Middle East 16-Year Perspective for Infertility Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 89: Middle East Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Middle East Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Middle East 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
IRAN
TABLE 92: Iran Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Iran Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Iran 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
ISRAEL
TABLE 95: Israel Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Israel Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Israel 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Saudi Arabia Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Saudi Arabia 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 101: UAE Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: UAE Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: UAE 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Rest of Middle East Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Rest of Middle East 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
AFRICA
Infertility Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 107: Africa Recent Past, Current & Future Analysis for Infertility Drugs by Product - Hormone-Based Therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Africa Historic Review for Infertility Drugs by Product - Hormone-Based Therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Africa 16-Year Perspective for Infertility Drugs by Product - Percentage Breakdown of Value Sales for Hormone-Based Therapy and Other Products for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings